Rapid Nutrition Enters Strategic Discussions to Expand SystemLS Brand into Europe
Rapid Nutrition initiates talks with a leading European distributor as part of its global expansion strategy, targeting the region’s USD 6.3B plant-based protein market.
London, United Kingdom – 13 May 2025 – Rapid Nutrition PLC (Euronext Growth: ALRPD), a global leader in natural health and wellness products, today announced that it has entered advanced discussions with a leading European nutritional distributor as part of a strategic initiative to launch its flagship brand, SystemLS, across the European market.
This development represents a significant milestone in Rapid Nutrition’s international expansion strategy and is expected to position the Company for enhanced long-term growth and value creation.
Europe’s protein powder market is projected to exceed USD 6.3 billion by 2028, driven largely by the surge in demand for plant-based, clean-label, and sustainably sourced nutrition. European consumers continue to prioritise transparency, ingredient integrity, and environmental sustainability—principles that are deeply embedded in the SystemLS product line, which features premium Australian-grown fava bean protein and is currently part of a major U.S.-based clinical study focused on health and nutrition outcomes of women over 50 with joint pain.
“Our entry into Europe marks a strategic step forward in our global rollout of SystemLS,” said Rapid Nutrition CEO Simon St. Ledger. “We are in discussions with a highly experienced European partner whose infrastructure and retail relationships could provide a strong commercial launchpad across key markets.”
A successful outcome from these discussions is expected to unlock significant revenue opportunities, providing further momentum to Rapid Nutrition’s growth trajectory and supporting long-term value creation for its shareholders. This potential partnership would further strengthen the Company’s global footprint by positioning it alongside experienced teams in strategic markets where it already maintains a presence—including Australia, the United States, China, and now Europe—enhancing both brand reach and operational depth across multiple high-growth regions.
Further updates will be provided as discussions progress.
About Rapid Nutrition
Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).